FDANonrulemakingFDA-2018-N-1621

Who commented on this docket

Patient-Focused Drug Development on Chronic Pain; Public Meeting; Request for Comments

1 organizations filed 1 public comment on Patient-Focused Drug Development on Chronic Pain; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 2878d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2878d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Patient-Focused Drug Development on Chronic Pain; Public Meeting; Request for Comments (FDA-2018-N-1621) | OpenPolis